Compare CGTX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGTX | LSBK |
|---|---|---|
| Founded | 2007 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 110.0M |
| IPO Year | 2021 | 2025 |
| Metric | CGTX | LSBK |
|---|---|---|
| Price | $1.03 | $15.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 848.8K | 5.4K |
| Earning Date | 01-01-0001 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $11.50 |
| 52 Week High | $3.83 | $16.73 |
| Indicator | CGTX | LSBK |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 60.66 |
| Support Level | $0.98 | $15.26 |
| Resistance Level | $1.04 | $15.75 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 23.91 | 70.83 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.